• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减瘤手术联合热灌注腹腔化疗治疗结直肠癌腹膜转移癌时麻醉管理对术中和术后结局的影响:一项系统评价方案

Impact of anesthesia management during cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for the treatment of colorectal peritoneal carcinomatosis on intra- and postoperative outcomes: A systematic review protocol.

作者信息

Idrissi Moulay, Espitalier Fabien, Coveney Richard, Bélanger Marie-Eve, Gobert Quentin, Sidéris Lucas, Dubé Pierre, Verdonck Olivier, Fortier Louis-Philippe, Richebé Philippe

机构信息

Maisonneuve-Rosemont Hospital Research Center (CR-HMR).

Department of Anesthesiology and Pain Medicine.

出版信息

Medicine (Baltimore). 2019 Jul;98(30):e16467. doi: 10.1097/MD.0000000000016467.

DOI:10.1097/MD.0000000000016467
PMID:31348249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6708794/
Abstract

BACKGROUND

The impact of the anesthesia management during cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of colorectal peritoneal carcinomatosis (CRPC) on postoperative outcomes might be of major importance in the process of postoperative recovery. It might have a significant impact on intra- and postoperative outcomes, but the evaluation of this impact seems to be under-reported. To investigate the question whether the anesthesia management was reported in previous studies done in this population and if it had any impact on postoperative outcomes, we propose to conduct a systematic review of the published literature.

METHODS

For this review, we will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P). Medline/PubMed, Embase, EBM Reviews and the Cochrane Database of Systematic Reviews (CDSR) will be systematically consulted for eligible studies without age, gender, ethnic, and language restriction. The goal of this review will be to assess whether anesthesia monitoring, dosing, and analgesia protocols were reported in this literature on this specific procedure and whether the impact of the anesthesia management on intraoperative safety and postoperative recovery was evaluated.

RESULTS

The results of this systematic review will allow to answer the initial question: has the impact of anesthesia management on intraoperative safety and patients' postoperative recovery already been studied and reported in the past for this type of major surgery? And does anesthesia have any impact on postoperative outcomes?

DISCUSSION

In the hypothesis that the impact of anesthesia management on patients' postoperative recovery has never been studied, or very little reported in previous studies in this type of major surgery, it would be justified to conduct a randomized controlled trial on this specific objective.

REGISTRATION

This systematic review protocol was registered in PROSPERO, under the registration number CRD42019124162.

摘要

背景

在减瘤手术(CRS)联合热灌注腹腔化疗(HIPEC)治疗结直肠癌腹膜转移癌(CRPC)过程中,麻醉管理对术后恢复的影响在术后恢复过程中可能至关重要。它可能对术中和术后结果产生重大影响,但对此影响的评估似乎报道不足。为了调查在该人群之前进行的研究中是否报道了麻醉管理以及它是否对术后结果有任何影响,我们建议对已发表的文献进行系统综述。

方法

对于本综述,我们将遵循系统评价与Meta分析方案的首选报告项目(PRISMA - P)。将系统查阅Medline/PubMed、Embase、循证医学综述和Cochrane系统评价数据库(CDSR)以获取符合条件的研究,不受年龄、性别、种族和语言限制。本综述的目的是评估关于该特定手术的文献中是否报道了麻醉监测、给药和镇痛方案,以及是否评估了麻醉管理对术中安全性和术后恢复的影响。

结果

本系统综述的结果将有助于回答最初的问题:过去对于这类大手术,麻醉管理对术中安全性和患者术后恢复的影响是否已经得到研究和报道?麻醉对术后结果有任何影响吗?

讨论

假设麻醉管理对患者术后恢复的影响从未被研究过,或者在这类大手术的先前研究中报道很少,那么针对这一特定目标进行一项随机对照试验将是合理的。

注册

本系统综述方案已在PROSPERO注册,注册号为CRD42019124162。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/6708794/5c8ea9be678a/medi-98-e16467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/6708794/5c8ea9be678a/medi-98-e16467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/6708794/5c8ea9be678a/medi-98-e16467-g001.jpg

相似文献

1
Impact of anesthesia management during cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for the treatment of colorectal peritoneal carcinomatosis on intra- and postoperative outcomes: A systematic review protocol.减瘤手术联合热灌注腹腔化疗治疗结直肠癌腹膜转移癌时麻醉管理对术中和术后结局的影响:一项系统评价方案
Medicine (Baltimore). 2019 Jul;98(30):e16467. doi: 10.1097/MD.0000000000016467.
2
Effect of hyperthermic intraperitoneal chemotherapy in combination with cytoreductive surgery on the prognosis of patients with colorectal cancer peritoneal metastasis: a systematic review and meta-analysis.腹腔内热灌注化疗联合细胞减灭术治疗结直肠癌腹膜转移患者的预后影响:系统评价和荟萃分析。
World J Surg Oncol. 2022 Jun 14;20(1):200. doi: 10.1186/s12957-022-02666-3.
3
[Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].1384例腹膜癌病患者接受细胞减灭术加腹腔内热灌注化疗的疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):230-239. doi: 10.3760/cma.j.cn.441530-20201110-00603.
4
Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness.细胞减灭术(CRS)联合腹腔内热灌注化疗(HIPEC)与标准治疗(SoC)对比治疗结直肠、卵巢或胃来源腹膜转移患者的系统评价和个体参与者数据(IPD)Meta 分析:有效性和成本效益研究方案。
BMJ Open. 2020 May 12;10(5):e039314. doi: 10.1136/bmjopen-2020-039314.
5
Impact of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-analysis.细胞减灭术联合腹腔热灌注化疗治疗胃癌腹膜转移的疗效:系统评价和荟萃分析。
Ann Surg Oncol. 2022 Nov;29(12):7528-7537. doi: 10.1245/s10434-022-12312-7. Epub 2022 Aug 5.
6
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.腹腔内热灌注化疗联合细胞减灭术的适应证:系统评价。
Eur J Cancer. 2020 Mar;127:76-95. doi: 10.1016/j.ejca.2019.10.034. Epub 2020 Jan 24.
7
Hyperthermic intraoperative peritoneal chemotherapy and cytoreductive surgery for people with peritoneal metastases: a systematic review and cost-effectiveness analysis.高热术中腹腔化疗联合细胞减灭术治疗腹膜转移患者的系统评价和成本效果分析。
Health Technol Assess. 2024 Sep;28(51):1-139. doi: 10.3310/KWDG6338.
8
Cytoreductive surgery plus hyperthermic intraoperative peritoneal chemotherapy for people with peritoneal metastases from colorectal, ovarian or gastric origin: A systematic review of randomized controlled trials.细胞减灭术联合腹腔内热灌注化疗治疗结直肠、卵巢或胃来源腹膜转移患者:随机对照试验的系统评价。
World J Surg. 2024 Jun;48(6):1385-1403. doi: 10.1002/wjs.12186. Epub 2024 Apr 24.
9
[Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].[关于减瘤手术联合腹腔热灌注化疗能否改善结直肠癌腹膜转移患者生存率的Meta分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):256-263. doi: 10.3760/cma.j.cn.441530-20201111-00604.
10
Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study.腹腔内热灌注化疗下细胞减灭术的目标导向治疗:一项前瞻性观察研究。
Clin Transl Oncol. 2019 Apr;21(4):451-458. doi: 10.1007/s12094-018-1944-y. Epub 2018 Sep 14.

本文引用的文献

1
Comparative effectiveness of hyperthermic intraperitoneal chemotherapy for gastric cancer: A systematic review and network meta-analysis protocol.热灌注腹腔化疗治疗胃癌的比较疗效:一项系统评价和网状Meta分析方案
Medicine (Baltimore). 2018 Aug;97(33):e11949. doi: 10.1097/MD.0000000000011949.
2
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数,1990 年至 2016 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Nov 1;4(11):1553-1568. doi: 10.1001/jamaoncol.2018.2706.
3
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.细胞减灭术联合腹腔热灌注化疗可提高结直肠癌腹膜转移癌患者的生存率:当前证据的系统评价和荟萃分析
Oncotarget. 2017 Apr 27;8(33):55657-55683. doi: 10.18632/oncotarget.17497. eCollection 2017 Aug 15.
4
Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines.结直肠源性腹膜转移瘤治疗的推荐意见与共识:对国内及国际指南的系统评价
Colorectal Dis. 2017 Mar;19(3):224-236. doi: 10.1111/codi.13593.
5
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review.2010-2015 年结直肠癌腹膜转移治疗进展的系统评价。
Crit Rev Oncol Hematol. 2016 Apr;100:209-22. doi: 10.1016/j.critrevonc.2016.01.017. Epub 2016 Jan 22.
6
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
7
Report on the 9(th) International Congress on Peritoneal Surface Malignancies.第九届国际腹膜表面恶性肿瘤大会报告
Cancer Biol Med. 2014 Dec;11(4):281-4. doi: 10.7497/j.issn.2095-3941.2014.04.008.
8
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.系统评价与Meta分析方案的首选报告项目(PRISMA-P)2015声明。
Syst Rev. 2015 Jan 1;4(1):1. doi: 10.1186/2046-4053-4-1.
9
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.美国腹膜表面恶性肿瘤学会(ASPSM)对1013例伴有腹膜癌转移的结直肠癌患者的腹膜表面疾病严重程度评分(PSDSS)进行的多机构评估。
Ann Surg Oncol. 2014 Dec;21(13):4195-201. doi: 10.1245/s10434-014-3798-z. Epub 2014 May 23.
10
Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy.结直肠癌细胞减灭术及围手术期化疗后腹膜转移的预后因素
ScientificWorldJournal. 2013 Apr 18;2013:978394. doi: 10.1155/2013/978394. Print 2013.